Industry News

The Role of R. mucosa in Reducing Eczema-Related Skin Inflammation

Research conducted by National Institute of Allergy and Infectious Diseases scientists leads to a new discovery.

Author Image

By: Christine Esposito

Editor-in-Chief

National Institutes of Allergy and Infectious Diseases (NIAID) at NIH.

Individuals with eczema experience imbalances in the microbiome and are deficient in certain skin lipids. Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) demonstrated that commensal bacterium Roseomonas mucosa can help restore lipids. R. mucosa-based topical interventions could simplify or complement current eczema management, when used in consultation with an individual’s healthcare provider, according to the researchers. Scientists led by Ian Myles, M.D.,...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters